Aurinia to Present at Bloom Burton & Co. Healthcare Conference
April 26 2017 - 9:17AM
Business Wire
Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today
announced that its Chief Executive Officer, Richard M. Glickman,
will present at the Bloom Burton & Co. Healthcare Conference in
Toronto, Ontario on May 2, 2017 at 11:30pm ET. A webcast will be
available and can be accessed via the investor section of the
Aurinia website, www.auriniapharma.com. A replay will also be
archived on the site following the event.
About AuriniaAurinia is a clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are suffering
from serious diseases with a high unmet medical need. The company
is currently developing voclosporin, an investigational drug, for
the treatment of lupus nephritis (LN), an inflammation of the
kidney caused by Systemic Lupus Erythematosus (SLE) and represents
a serious progression of SLE. The company is headquartered in
Victoria, BC and focuses its development efforts globally.
www.auriniapharma.com.
We Seek Safe Harbor.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170426005818/en/
Aurinia Pharmaceuticals Inc.Investor & Media
Contact:Celia EconomidesHead of IR &
Communicationsceconomides@auriniapharma.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Sep 2023 to Sep 2024